The Technical Analyst
Milestone Scientific Inc [MLSS]
Exchange: AMEX Industry: Medical Instruments & Supplies
Milestone Scientific Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.23% $0.571
America/New_York / 18 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 43.77 mill |
| EPS: | -0.100 |
| P/E: | -5.71 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 76.60 mill |
| Avg Daily Volume: | 0.0740 mill |
| RATING 2024-04-18 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -5.71 | sector: PE 12.30 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.02x |
| Company: PE -5.71 | industry: PE 351.26 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.514 - 0.628 ( +/- 9.98%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-12-11 | Goldman Neal I | Buy | 125 000 | Common Stock, Par Value $0.001 |
| 2023-10-19 | Trombetta Giandomenico | Sell | 2 000 | Common Stock, Par Value $0.001 |
| 2023-10-23 | Trombetta Giandomenico | Sell | 1 400 | Common Stock, Par Value $0.001 |
| 2023-10-18 | Trombetta Giandomenico | Sell | 3 000 | Common Stock, Par Value $0.001 |
| 2023-10-19 | Trombetta Giandomenico | Sell | 18 600 | Common Stock, Par Value $0.001 |
| INSIDER POWER |
|---|
| 86.14 |
| Last 99 transactions |
| Buy: 2 744 603 | Sell: 834 971 |
Forecast:
16:00 - $0.563
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.563
Forecast 2: 16:00 - $0.563
Forecast 3: 16:00 - $0.563
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.571 (0.23% ) |
| Volume | 0.100 mill |
| Avg. Vol. | 0.0740 mill |
| % of Avg. Vol | 135.57 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MLSS
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MLSS
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
Latest Press Releases
2024-04-01 07:00:00 - Press Release
Milestone Scientific Achieves 12% Increase In Revenue And 39% Increase In Gross Profit For The Year Ended 2023
Reports acceleration of reimbursement claims submission for the compuflo® epidural system technology reports acceleration of reimbursement claims submission for the compuflo® epidural system technology
2024-03-28 11:45:00 - Press Release
Milestone Scientific Schedules 2023 Year-end Financial Results And Business Update Conference Call
Roseland, n.j., march 28, 2024 (globe newswire) -- milestone scientific inc. (nyse:mlss), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 am eastern time on monday, april 1, 2024, to discuss the company's financial results for 2023, as well as the company's corporate progress and other developments
2024-03-14 08:30:00 - Press Release
Milestone Scientific Commences Sales Of Compuflo® Epidural Disposables Within Omaha Pain Physicians
Follows successful evaluation by omaha pain physicians' founder and medical director, dr. matthew stottle, reporting 100% success follows successful evaluation by omaha pain physicians' founder and medical director, dr. matthew stottle, reporting 100% success
2024-02-28 08:30:00 - Press Release
Milestone Scientific Commences Direct Sales Of Sta Single Tooth anesthesia System® With Meridian Endo & Perio
Roseland, n.j., feb. 28, 2024 (globe newswire) -- milestone scientific inc. (nyse:mlss), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced direct sales of its sta single tooth anesthesia system® (sta) with meridian endo & perio, a large endodontics, periodontics and implant dentistry practice with three offices in wisconsin.
2024-02-20 08:30:00 - Press Release
Milestone Scientific Commences Direct Sales Of Sta Single Tooth Anesthesia System® To Maine Dental Group, A Premier Group Practice With 21 Locations across The Northeast
Roseland, n.j., feb. 20, 2024 (globe newswire) -- milestone scientific inc. (nyse:mlss), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced sales of its sta single tooth anesthesia system® (sta) with maine dental group, a premier group of 21 dental practices across the northeastern united states.
Latest News
2024-03-28 11:45:00 - GlobeNewsWire
Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call
ROSELAND, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Monday, April 1, 2024, to discuss the company's financial results for 2023, as well as the company's corporate progress and other developments
2023-11-10 08:30:00 - GlobeNewsWire
Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call
ROSELAND, N.J., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, November 15, 2023, to discuss the company's financial results for the third quarter ended September 30, 2023, as well as the company's corporate progress and other developments.
2023-08-15 12:41:09 - Seeking Alpha
Milestone Scientific Inc. (MLSS) Q2 2023 Earnings Call Transcript
Milestone Scientific Inc. (NYSE:MLSS ) Q2 2023 Earnings Conference Call August 15, 2023 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Peter Milligan - Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group Tucker Andersen - Above All Advisors Operator Greetings, and welcome to the Milestone Scientific Second Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
2023-06-15 18:41:42 - Seeking Alpha
Milestone Scientific: Buy For The $4 Billion Total Addressable Market
Milestone Scientific offers an innovative product line in the medical and dental segments, including a trademarked solution for Dentists to administer local anesthesia called SingleTooth Anesthesia. The company meets key investment criteria such as a large total addressable market, low institutional ownership, and high Quant ratings. Despite the high level of risk associated with micro caps, I recommend building a small position in the stock for risk-tolerant investors due to its significant upside potential.
2023-06-15 11:00:00 - GlobeNewsWire
Milestone Scientific to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20th
ROSELAND, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that Arjan Haverhals, CEO of Milestone Scientific will be presenting at the Maxim Group Virtual Healthcare Conference, hosted by M-Vest, which is being held June 20-22, 2023.
2023-06-10 23:52:58 - Seeking Alpha
Milestone Scientific: Sales Could Start To Snowball
The shift to online sales in their dental business produced unexpectedly fast results with revenue and gross margin up sharply and more to come. Most if not all of the pieces necessary for CompuFlo sales to take off are now in place, sales could start to snowball this year. In years to come, CompuFlo could even become the standard of care.
2023-05-05 11:00:00 - GlobeNewsWire
Milestone Scientific Schedules First Quarter 2023 Financial Results and Business Update Conference Call
ROSELAND, N.J., May 05, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 11, 2023, to discuss the company's financial results for the first quarter ended March 31, 2023, as well as the company's corporate progress and other developments.
2023-03-31 19:34:07 - Seeking Alpha
Milestone Scientific Inc. (MLSS) Q4 2022 Earnings Call Transcript
Milestone Scientific Inc. (NYSE:MLSS ) Q4 2022 Results Conference Call March 31, 2023 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Peter Milligan - Chief Financial Officer of Milestone Scientifi Conference Call Participants Anthony Vendetti - Maxim Group Mike Pfeffer - Oppenheimer Operator Greetings. Welcome to the Milestone Scientific 2022 Year-end Financial Results and Business Update Conference Call.
2023-03-29 08:30:00 - GlobeNewsWire
Milestone Scientific Schedules 2022 Year-End Financial Results and Business Update Conference Call
ROSELAND, N.J., March 29, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, March 31, 2023, to discuss the company's financial results for 2022, as well as the company's corporate progress and other developments.
2022-11-15 10:26:05 - Seeking Alpha
Milestone Scientific Inc. (MLSS) Q3 2022 Earnings Call Transcript
Milestone Scientific Inc. (NYSE:MLSS ) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Conference Call Participants Anthony Vendetti - Maxim Group Operator Good day ladies and gentlemen and welcome to the Milestone Scientific's Third Quarter 2022 Business Update Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation.